We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03552029
Brief Title: Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML)

First Submitted : May 17, 2018
First Submitted that Met QC Criteria : May 29, 2018
First Posted : June 11, 2018

Results First Submitted : December 13, 2021
Results First Submitted that Met QC Criteria : March 14, 2022
Results First Posted : May 20, 2022

Last Update Submitted that Met QC Criteria : March 14, 2022
Last Update Posted : May 20, 2022